HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Richard H. Dal Col Bartley P. Griffith Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dal Col, R. H. Articles by Griffith, B. P. Search for Related Content PubMed PubMed Citation Articles by Dal Col, R. H. Articles by Griffith, B. P.

Ann Thorac Surg 1990;49:754-758
© 1990 The Society of Thoracic Surgeons

---

Articles

Donor-specific cytotoxicity testing: An advance in detecting pulmonary allograft rejection

Departments of Surgery and Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

^_* Address reprient to Dr Griffith, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.

Ten beagle dogs underwent left unilateral lung transplantion and were treated with cyclosporine and azathioprine. After three days, cyclosporine administration was discontinued and azathioprine administration was maintained at a suboptimal dose to allow a graded response to the pulmonary allograft. Dogs were monitored by chart roentgenogram, bronchoalveolar lavage (BAL), and sampling of peripheral blood lymphocytes at weekly intervals. Open, lung biopsies also were performed at weekly intervals in 5 of the dogs. Lymphocytes from the BAL and peripheral blood and these grown in culture from open and calcific biopsy specimens were tested for donor-specific cytntoxicity (DSC) by testing their responsiveness to lymphocytes from their donor. Rejection was confirmed in all animals. Donor-specific cytotoxicity became detectable in all animals in either the BAL fluid or biopsy specimens. An abnormal chest roentgenogram developed in 9 dogs, but not until after DSC was detected in the BAL in 7. In the open biopsy specimens tested for DSC, all exhibited DSC synchronous with the first changes noted on chest roentgenogram. Donor-specific cytotoxicity was sensitive for detecting rejection in 8 of 9 dogs in the BAL and in 5 of 5 dogs in the open biopsy specimens. Based on these results, 3 additional dogs were maintained on cyclosporine. Two of these dogs did not reject their transplants and had no evidence of DSC. We conclude that donor-specific functional assays provide an advance over less sensitive clinical techniques.

This article has been cited by other articles:

				E. Wagner, R. Roy, Y. Marois, Y. Douville, and R. Guidoin FRESH VENOUS ALLOGRAFTS IN PERIPHERAL ARTERIAL RECONSTRUCTION IN DOGSEffects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1732 - 1744. [Abstract] [Full Text]

				R. Ruggiero, R. Fietsam Jr., G. A. Thomas, J. Muz, R. H. Farris, T. A. Kowal, J. L. Myles, L. W. Stephenson, and F. A. Baciewicz Jr. Detection of canine allograft lung rejection by pulmonary lymphoscintigraphy J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 253 - 258. [Abstract] [Full Text]

				H. Shennib and D. Nguyen Bronchoalveolar lavage in lung transplantation Ann. Thorac. Surg., February 1, 1991; 51(2): 335 - 340. [Abstract] [PDF]